These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15513664)

  • 21. The Philadelphia High-School STD Screening Program: key insights from dynamic transmission modeling.
    Fisman DN; Spain CV; Salmon ME; Goldberg M
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S61-5. PubMed ID: 18607306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating adolescents in juvenile detention facilities for urogenital chlamydial infection: costs and effectiveness of alternative interventions.
    Mrus JM; Biro FM; Huang B; Tsevat J
    Arch Pediatr Adolesc Med; 2003 Jul; 157(7):696-702. PubMed ID: 12860793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up.
    Morré SA; van den Brule AJ; Rozendaal L; Boeke AJ; Voorhorst FJ; de Blok S; Meijer CJ
    Int J STD AIDS; 2002 Dec; 13 Suppl 2():12-8. PubMed ID: 12537719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands.
    van Bergen J; Götz HM; Richardus JH; Hoebe CJ; Broer J; Coenen AJ;
    Sex Transm Infect; 2005 Feb; 81(1):17-23. PubMed ID: 15681716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of costs, effectiveness, and disease control of a population-based program using home sampling for diagnosis of urogenital Chlamydia trachomatis Infections.
    Andersen B; Gundgaard J; Kretzschmar M; Olsen J; Welte R; Oster-Gaard L
    Sex Transm Dis; 2006 Jul; 33(7):407-15. PubMed ID: 16601656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of the burden of disease and costs of genital Chlamydia trachomatis infection in Canada.
    Tuite AR; Jayaraman GC; Allen VG; Fisman DN
    Sex Transm Dis; 2012 Apr; 39(4):260-7. PubMed ID: 22421691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The C-project: use of self-collection kits to screen for Chlamydia trachomatis in young people in a community-based health promotion project.
    Martin L; Freedman E; Burton L; Rutter S; Knight V; D'Amato A; Murray C; Drysdale J; Harvey S; McNulty A
    Sex Health; 2009 Jun; 6(2):157-62. PubMed ID: 19457296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis by PCR in genitourinary specimens from men and women attending an STD clinic.
    Bhalla P; Baveja UK; Chawla R; Saini S; Khaki P; Bhalla K; Mahajan S; Reddy BS
    J Commun Dis; 2007 Mar; 39(1):1-6. PubMed ID: 18338709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.
    van Valkengoed IG; Postma MJ; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Sex Transm Infect; 2001 Aug; 77(4):276-82. PubMed ID: 11463928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlamydia trachomatis prevalence in men in the mid-west of Ireland.
    Powell J; O'Connor C; O'hlarlaithe M; Saunders J; De Freitas J
    Sex Transm Infect; 2004 Oct; 80(5):349-53. PubMed ID: 15459401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
    van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Universal screening or prophylactic treatment for Chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective?
    Chen S; Li J; van den Hoek A
    Sex Transm Dis; 2007 Apr; 34(4):230-6. PubMed ID: 17414068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].
    Postma MJ; Welte R; van den Hoek JA; Jager JC; van Doornum GJ; Coutinho RA
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2383-5. PubMed ID: 10590778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chlamydia trachomatis: should it be systematically be screened or treated? Literature review and cost/benefit estimation in France].
    Henry-Suchet J; Sluzhinska A; Serfaty D
    Contracept Fertil Sex; 1998 Feb; 26(2):151-8. PubMed ID: 9560916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prediction rule for selective screening of Chlamydia trachomatis infection.
    Götz HM; van Bergen JE; Veldhuijzen IK; Broer J; Hoebe CJ; Steyerberg EW; Coenen AJ; de Groot F; Verhooren MJ; van Schaik DT; Richardus JH
    Sex Transm Infect; 2005 Feb; 81(1):24-30. PubMed ID: 15681717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlamydia trachomatis genital infection in apparently healthy adult population of Tamil Nadu, India: a population-based study.
    Joyee AG; Thyagarajan SP; Rajendran P; Hari R; Balakrishnan P; Jeyaseelan L; Kurien T;
    Int J STD AIDS; 2004 Jan; 15(1):51-5. PubMed ID: 14769173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and cost-effectiveness of a pharmacy-based screening programme for Chlamydia trachomatis in a high-risk health centre population in Amsterdam using mailed home-collected urine samples.
    van Bergen JE; Postma MJ; Peerbooms PG; Spangenberg AC; Tjen-A-Tak J; Bindels PJ
    Int J STD AIDS; 2004 Dec; 15(12):797-802. PubMed ID: 15601485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Home sampling and pooling of vaginal samples are effective tools for genetic screening of Chlamydia trachomatis among high school female students in Lithuania.
    Kucinskiene V; Juseviciute V; Valiukeviciene S; Milasauskiene Z; Unemo M; Domeika M
    Scand J Infect Dis; 2008; 40(2):88-93. PubMed ID: 17852902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chlamydia trachomatis infection in central Norway--testing patterns and prevalence].
    Bakken IJ; Nordbø SA
    Tidsskr Nor Laegeforen; 2007 Dec; 127(24):3202-5. PubMed ID: 18084360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chlamydia trachomatis detection in cervical PreservCyt specimens from an Irish urban female population.
    Keegan H; Ryan F; Malkin A; Griffin M; Lambkin H
    Cytopathology; 2009 Apr; 20(2):111-6. PubMed ID: 18093220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.